Faculty and Staff Detail
|
Bill Wade, Pharm.D., FASHP, FCCP Kroger Professor CET PCA Clinical Administrative Pharmacy |
| Contact Information | |
|---|---|
| Phone: | (706)542-5316 |
| Email: | bwade@mail.rx.uga.edu |
| Fax: | (706)542-5228 |
| Office: | 250J |
| Address: |
R.C. Wilson Pharmacy Building 250 Green Street UGA College of Pharmacy Athens, GA 30602-2354 |
| Biosketch | |||
|---|---|---|---|
| BS Pharmacy | University of Georgia | Athens, GA | 1975 |
| Pharm. D. | University of Georgia | Athens, GA | 1985 |
- Honors and Awards
- Fellow ASHP
Fellow ACCP
Diplomate American Academy of Pain Management
ASHP Pharmacy Practice Research Award
ASCP First Place Award for Contributed Papers
GPhA Best Publication Award
- Area of Expertise
- Pharmacoeconomics
Thromboembolism Prophylaxis
Viral Hepatitis
Clinical Pharmacokinetics
Pain Management
Adult Total Parenteral Nutritional Support
- Representative Publications
- Wade WE, Spruill WJ, Leslie R. Cost analysis: Fondaparinux versus preoperative and postoperative enoxaparin as venous thromboembolic event prophylaxis in elective hip arthroplasty. Am J Orthop 2003; 32 (4): 201-205.
Spruill WJ, Wade WE. Curricular and content survey of clinical pharmacokinetics courses. Am J Pharm Ed 2003; 67(2) Article 16.
Spruill WJ, Wade WE, Leslie R. Determining institution specific costs of thromboembolic events using an algorithm and spreadsheet approach. Am J Health-Syst Pharm 2003; 60:1741-1749.
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beer’s criteria for potentially inappropriate medication use in older adults: results of a U.S. consensus panel of experts. Arch Intern Med 2003; 163:2716-2724.
Spruill WJ, Wade WE, Taylor AT, Burke SI, Longe RL. A survey of pharmacists opinions on both the value of and reasons for providing various pharmaceutical care services. J Soc Adm Pharm 2003; 20(6): 213-218.
Spruill WJ, Wade WE. Cancer awareness and prevention activities: Assessment of pharmacists knowledge and interest. J Am Pharm Assoc 2004(1);44:94-98
Spruill WJ, Wade WE, Leslie R. A cost analysis of fondaparinux versus enoxaparin in total knee arthroplasty. Am J Ther 2004; 11(1): 3-8.
Wade WE, Spruill WJ, Leslie R. Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in hip fracture surgery. Am J Ther 2004; 11(3): 194-198.
Spruill WJ, Wade WE, Leslie R. A cost analysis of fondaparinux versus enoxaparin in elective hip replacement surgery. Blood Coagulation and Fibrinolysis 2004; 15: 539-43.
Deshpande A, Wade WE, Johnson T, Franic DM. A survey of pharmacy student involvement in wellness programs. Am J Pharm Edu 2004; 68(5) Article 122.
Cook CL, Wade WE, Martin B, Perri M. Correlations between three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc 2005; 45(2): 151-59.
Cooper JW, Wade WE. Pharmacist interventions in geriatric nursing facility NSAID therapy: A one year follow-up study of costs and outcomes. The Consultant Pharmacist 2005; 20(6): 492-497.
Wade WE, Spruill WJ, Leslie R. Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in hip fracture surgery. Am J Ther 2004; 11(3): 194-198.
Wade WE, Spruill WJ. New Serum Creatinine Assay Standardization: Implications for Drug Dosing. Ann Pharmacother 2007; (March) 41: 475-480.
Wade WE, Spruill WJ. Fondaprainux sodium in the prophylaxis and treatment of
deep vein thrombosis and pulmonary embolism. Expert Rev Pharmacoeconomics
Outcomes Res 2007; 7 (3): 227-237. Invited Publication